<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02809248</url>
  </required_header>
  <id_info>
    <org_study_id>15-123</org_study_id>
    <nct_id>NCT02809248</nct_id>
  </id_info>
  <brief_title>The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study)</brief_title>
  <official_title>The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX-Stent Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to choose an optimal stent and to get further knowledge about the
      mechanisms of the engraftment of a stent.

      The occurrence of a hyperplasia of neointima can be minimized by application of a coated
      stent and a concurrent safety four weekly dual thrombocytes therapy
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the ideal stent (coated stent or uncoated stent)</measure>
    <time_frame>5 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Re-stenosis</condition>
  <condition>Cirrhosis of the Liver</condition>
  <arm_group>
    <arm_group_label>coated stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the patient get a coated coronary stent implantation (ZES - zotarolimus eluting stent)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>uncoated stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the patient get a uncoated coronary stent implantation (BMS - bare metal stent)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ZES</intervention_name>
    <description>stent implantation (zotarolimus eluting stent)</description>
    <arm_group_label>coated stent</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BMS</intervention_name>
    <description>stent implantation (bare metal stent)</description>
    <arm_group_label>uncoated stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male and female patients with a severe dysfunction of liver

          -  patient is planned a coronary stent implantation

          -  adults who are contractually capable and mentally able to understand and follow the
             instructions of the study personnel

          -  written informed consent prior to study participation

        Exclusion Criteria:

          -  younger than 18 years

          -  pregnancy and breast-feeding

          -  acute cardiac syndrome

          -  contraindication against an intracardiac catheter

          -  persons in dependence from the sponsor or working with the sponsor

          -  participation in a parallel interventional clinical trial

          -  patient has been committed to an institution by legal or regulatory order
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Becker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uniklinik RWTH Aachen, Med. Klinik I</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Becker, MD</last_name>
    <phone>+49 0241 80 36083</phone>
    <email>mibecker@ukaachen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marc Hein, MD</last_name>
    <phone>+49 0241 80 88172</phone>
    <email>mhein@ukaachen.de</email>
  </overall_contact_backup>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2016</study_first_submitted>
  <study_first_submitted_qc>June 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2016</study_first_posted>
  <last_update_submitted>July 7, 2016</last_update_submitted>
  <last_update_submitted_qc>July 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>LTX Study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Coronary Restenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

